SEC Contract Filing

Filing Date: 2025-05-28

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d911818dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORIC PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>Securities Purchase Agreement </B>(the &#147;<B><I>Agreement</I></B>&#148;) is made as of May&nbsp;23, 2025 (the &#147;<B><I>Effective
Date</I></B>&#148;), by and among <B>ORIC Pharmaceuticals, Inc.</B>, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a
&#147;<B><I>Purchaser</I></B>&#148; and, collectively, the &#147;<B><I>Purchasers</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Purchasers desire
to purchase, and the Company has agreed to sell, 14,130,313 shares of the Company&#146;s common stock, par value $0.0001 per share (the &#147;<B><I>Common Stock</I></B>&#148;) and 5,100,532 <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrants
to purchase Common Stock in the form attached hereto as <U>Exhibit A</U> (the &#147;<B><I><FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants</I></B>&#148;), for a purchase price of $6.50 per share and $6.4999 per <FONT
STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant and aggregate gross proceeds to the Company of approximately $125&nbsp;million. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Purchasers hereby agree, severally and not jointly,
as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 1 AUTHORIZATION OF SALE OF SECURITIES. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has authorized the sale and issuance of shares of its Common Stock and <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants
to the Purchasers on the terms and subject to the conditions set forth in this Agreement. The shares of Common Stock that may be sold to the Purchasers hereunder at the Closing (as defined in <U>Section</U><U></U><U>&nbsp;3.1</U>) shall be referred
to as the &#147;<B><I>Shares</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 2 AGREEMENT TO SELL AND PURCHASE THE SECURITIES. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Purchase</U>. At the Closing, the Company will issue, sell and deliver to each Purchaser, and such Purchaser will purchase from the
Company, that number of Shares and/or <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants set forth below such Purchaser&#146;s name on its signature page hereto, for the purchase price set forth therein (the &#147;<B><I>Purchase
Price</I></B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Definitions</U>. For purposes of this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B><I>Affiliate</I></B>&#148; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act (as defined in <U>Section</U><U></U><U>&nbsp;4.3</U> below). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B><I>Business Day</I></B>&#148; means a day, other than a Saturday or Sunday, on which banks in New York City are open for the
general transaction of business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B><I>Law</I></B>&#148; means any federal, state, local or foreign law (including common law),
statute, code, ordinance, rule, regulation, order, judgment, writ, stipulation, award, injunction, decree, arbitration award or finding or any other legally enforceable requirement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B><I>Material Adverse Effect</I></B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.1</U>. </P>
</DIV></Center>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B><I>Person</I></B>&#148; means an individual, corporation, partnership, limited
liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, go